期刊文献+

大鼠盆底重建组织工程补片的初步构建及其在体研究 被引量:3

Primary fabrication of a tissue-engineered mesh for pelvic floor reconstruction and research in vivo
原文传递
导出
摘要 目的 初步探讨自体来源脂肪间充质干细胞(ADSC)复合丝素蛋白支架构建盆底重建组织工程补片的可行性.方法 分离培养大鼠ADSC,扩增后种植于丝素蛋白溶液与丝素纤维网片冻干而成的支架上,制备组织工程补片,并观察形态.将组织工程补片植入相应大鼠皮下,对照组植入丝素蛋白支架.观察其在体组织化、力学性能及胶原形成情况.结果 ADSC体外增殖良好,丝素蛋白支架由编织部分与海绵部分组成,ADSC可黏附于支架并形成细胞层.组织工程补片在体生物相容性好,最大失效力(3.081 N±0.121 N比2.167 N±0.148 N)、杨氏模量(3.191 MPa±0.146 MPa比2.263 MPa±0.213 MPa)及胶原含量(18.648 μg/mg±0.867 μg/mg比14.123 μg/mg±0.989μg/mg)均优于对照组(P<0.05).结论 组织工程补片可满足盆底重建要求,具有良好应用前景. Objective To explore the fabrication of a tissue-engineered mesh fabricated with autologous adipose-derived mesenchymal stem cells (ADSC) and silk fibroin scaffold for female pelvic reconstruction.Methods Sprague-Dawley rat adipose tissue was obtained from inguinal region.Mesenchymal stem cells were isolated and proliferated in vitro.The sericin of silk was removed after knitting in to web.Then a compound scaffold freeze-dried of silk fibroin web and silk fibroin solution was prepared for ADSC seeding.after 1-week culturing,the cellular morphology and extracellular matrix secretion on scaffold were observed by scanning electronic microscopy.The tissue-engineered meshes were implanted subcutaneously into the homologous rats while silk fibroin scaffolds served as control.Then the biomechanics,collagen matrix and local tissue response to tissue-engineered meshes in vivo with that to silk fibroin scaffolds were estimated.Results ADSC were fibroblast-like and proliferated well in vitro.SEM showed that the scaffold had an interwoven structure with a smooth surface and the silk sponges in scaffold had a uniform and porous structure.ADSC adhered firmly to the scaffold,secreted extracellular matrix and formed cell sheets on scaffold.In vivo studies showed that the tissue matrix of tissue-engineered meshes was better organized than silk fibroin scaffolds.They also had higher failure force (3.081 ±0.121 vs 2.167 ±0.148 N) and Young's modulus (3.191 ± 0.146 vs 2.263 ± 0.213 M Pa) and more collagen content (18.648 ± 0.867 vs 14.123 ± 0.989 μg/mg) than silk fibroin scaffolds (P 〈 0.05).Conclusion As a suitable cell type for tissue engineering,ADSC may be successfully isolated and stably proliferated in vitro.The tissue-engineered meshes have an excellent biocompatibility and appropriate properties for pelvic floor reconstruction.
出处 《中华医学杂志》 CAS CSCD 北大核心 2014年第41期3273-3276,共4页 National Medical Journal of China
基金 北京市自然科学基金(7122194) 北京大学“985工程”(临床医院合作专项)建设项目(51917715021801203)
关键词 盆底功能障碍性疾病 组织工程 成体干细胞 组织支架 Pelvic floor disorders Tissue engineering Adult stem cells Tissue scaffold
  • 相关文献

参考文献8

  • 1Swift SE, Tate SB, Nicholas J. Correlation of symptoms with degree of pelvic organ support in a general population of women : what is pelvic organ prolapse? [ J]. Am J Obstet Gynecol,2003,189: 372-377.
  • 2Haylen BT, Sand PK, Swift SE, et al. Transvaginal placement of surgical mesh for pelvic organ prolapse: more FDA concerns- positive reactions are possible [ J ]. Int Urogynecol J, 2012,23 : 11-13.
  • 3Hung M J, Wen MC, Hung CN, et al. Tissue-engineered fascia from vaginal fibroblasts for patients needing reconstructive pelvic surgery[ J]. Int Urogyneeol J,2010,21 : 1085-1093.
  • 4Park A, Hogan MCV, Kesturu GS, et al. Adipose-derived mesenchymal stem cells treated with growth differentiation factor-5 express tendon-specific markers [ J ]. Tissue Eng Part A, 2010, 16:2941-2951.
  • 5Liu H, Fan H, Wang Y, et al. The interaction between a combined knitted silk scaffold and mieroporous silk sponge with human mesenchymal stem cells for ligament tissue engineering [ J ]. Biomaterials, 2008,29 : 662 -674.
  • 6Grant RA. Estimation of hydroxyproline by the autoanalyser[ J]. J Clin Pathol, 1964,17:685-686.
  • 7O'Brien FJ. Biomaterials & scaffolds for tissue engineering[J]. Mater Today ,2011,14:88-95.
  • 8李慧,孙凌云.间质干细胞的免疫调节及免疫治疗作用研究进展[J].中华医学杂志,2006,86(7):501-503. 被引量:15

二级参考文献23

  • 1张伟,葛薇,李长虹,尤胜国,韩钦,邓为民,赵春华.骨髓间充质干细胞通过上调CD8^+CD28^-T细胞抑制T细胞的增殖[J].中国实验血液学杂志,2004,12(5):666-669. 被引量:17
  • 2宁红梅,金建刚,扈江伟,冯凯,陈虎.人骨髓间充质干细胞体外对异基因T淋巴细胞表型的影响[J].中国实验血液学杂志,2005,13(1):43-49. 被引量:22
  • 3江小霞,张毅,李秀森,吴英,于晓妉,唐佩弦,毛宁.间充质干细胞对T淋巴细胞转化的影响[J].解放军医学杂志,2005,30(2):130-132. 被引量:10
  • 4Pittinger M,Mackay A,Beck S,et al.Multilineage potential of adult human mesenchymal stem cells.Science,1999,284:143-147.
  • 5Li Y,Hisha H,Inaba M,et al.Evidence for migration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts:a role of stromal cells in positive selection.Exp Hematol,2000,28:950-960.
  • 6Le Blanc K,Tammik L,Zetterberg E,et al.HLA-expression and immunologic properties of undifferentiated and differentiated mesenchymal stem cells.Exp Hematol,2003,31:890-896.
  • 7Tse WT,Pendleton JD,Beyer WM,et al.Suppression of allogeneic T-cell proliferation by human marrow stromal cells:implications in transplantation.Transplantation,2003,75:389-397.
  • 8Rasmusson I,Ringden O,Sundberg B,et al.Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms.Exp Cell Res,2005,305:33-41.
  • 9Bartholomew A,Sturgeon C,Siatskas M,et al.Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.Exp Hematol,2002,30:42-48.
  • 10Di Nicola M,Carlo-Stella C,Magni M,et al.Human bone marrow stromal cells suppress T-lymohocyte proliferation induced by cellular or nonspecific mitogenic stimuli.Blood,2002,99:3838-3843.

共引文献14

同被引文献39

  • 1张晓红,王建六,金玲,王世军,魏丽惠.补片在女性盆底重建手术的应用-18例临床分析[J].中国妇产科临床杂志,2006,7(1):9-12. 被引量:56
  • 2蔡丽萍,易为民,朱虹,涂春华.补片在女性盆底功能障碍性疾病中的应用[J].实用临床医学(江西),2006,7(9):100-103. 被引量:15
  • 3Ellington DR, Richter HE.indications, contraindications, and complications of mesh in surgical treatment of pelvic organ prolapse.Clin Obstet Gynecol. 2013; 56(2):276-288.
  • 4Mourtzinos'A,Maher MG, Raz S,et aI.Spiral sling salvage anti-incontinence surgery for women with refractory stress urinary incontinence: surgical outcome and satisfaction determined by patient-driven questionnaires.Urology. 2008 72(5): 1044-1048.
  • 5Peacock O, Simpson JA, Tou SI,et aI.Outcomes after biological mesh reconstruction of the pelvic floor following extra-levator abdominoperineal excision of rectum (APER) Tech Coloproctol. 2014;18(6):571-577.
  • 6Ashok K, Petri E.Failures and complications in pelvic floor surgery.World J Urol. 2012;30(4):487-94.
  • 7Gold KP, Ward RM, Zimmerman CW, et al.Factors associated with exposure of transvaginally placed polypropylene mesh for pelvic organ prolapse.lnt Urogynecol J. 2012;23(10): 1461-1466.
  • 8Haylen BT, Freeman RM, Lee J, et al.An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classification of the complications related to native tissue female pelvic floor surgery.lnt Urogynecol J. 2012;23(5):515-526.
  • 9Elmer C, Falconer C, Hallin A, et al.Risk factors for mesh complications after trocar guided transvaginal mesh kit repair of anterior vaginal wall prolapse.Neurourol Urodyn. 2012; 31(7): 1165-1169.
  • 10Aboushwareb T, McKenzie P, Wezel F, et al.ls tissue engineering and biomaterials the future for lower urinary tract dysfunction (LUTD)/pelvic organ prolapse (POP)?Neurourol Urodyn. 2011 ;30(5):775-782.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部